⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16645716 | 0.96 | TTR (0.43) | — | |
| SCHEMBL2621587 | 0.87 | — | — | |
| SCHEMBL1558663 | 0.83 | ALDH1A1 (0.42) | — | |
| SCHEMBL256779 | 0.79 | — | — | |
| SCHEMBL256063 | 0.78 | — | — | |
| Tetrahydrofuran SCHEMBL11376923 | 0.76 | ALDH1A1 (0.50) | — | |
| SCHEMBL1558955 | 0.74 | — | — | |
| SCHEMBL64228 | 0.73 | — | — | |
| SCHEMBL15033958 | 0.72 | — | — | |
| SCHEMBL12377395 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10683293-B2 | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases | NUEVOLUTION A/S (DK) | 2020-06-16 | — | — | US | claimed |
| EP-0747374-B1 | Sulfonamido substituted benzopyran potassium channel activators | BRISTOL MYERS SQUIBB CO (US) | 2001-12-12 | — | — | EP | claimed |
| US-5869478-A | ADMINISTERING AS ANTIISCHEMIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-02-09 | — | — | US | claimed |
| US-5629429-A | Process for preparing 4-arylamino-benzopyran and related compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-05-13 | — | — | US | claimed |
| EP-0747374-A1 | Sulfonamido substituted benzopyran potassium channel activators | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | claimed |
| EP-4658640-A1 | PYRIDIN-2(1H)-ONES AND PYRIMIDIN-4(3H)-ONES AS NLRP3 INHIBITORS | Janssen Pharmaceutica NV (BE) | 2025-12-10 | — | — | EP | disclosed |
| US-20250325469-A1 | Inhibitors of atp synthase - cosmetic and therapeutic uses | FORREST MICHAEL DAVID (GB) | 2025-10-23 | — | — | US | disclosed |
| US-12410143-B2 | Therapeutic inhibitors of the reverse mode of ATP synthase | FORREST MICHAEL DAVID (GB) | 2025-09-09 | — | — | US | disclosed |
| US-12337000-B2 | Therapeutic modulators of the reverse mode of ATP synthase | FORREST MICHAEL DAVID (GB) | 2025-06-24 | — | — | US | disclosed |
| US-12266758-B2 | Polymer electrolyte for a solid state battery | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. (US) | 2025-04-01 | — | — | US | disclosed |
| US-20250057851-A1 | Therapeutic Modulators of the Reverse Mode of ATP Synthase | FORREST MICHAEL DAVID (GB) | 2025-02-20 | — | — | US | disclosed |
| US-20240392249-A1 | HUMAN HEPATOCYTE CULTURE MEDIUM AND CONDITIONED MEDIUM OF IN VITRO CULTURED HUMAN HEPATOCYTES AND USES THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-11-28 | — | — | US | disclosed |
| US-6040367-A | EXCELLENT RESISTANCE TO AN IONIZING RADIATION, IN WHICH HETEROCYCLIC COMPOUND CONTAINING OXYMETHYLENE UNITS | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5977206-A | Polycarbonate resin composition | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-11-02 | — | — | US | disclosed |
| US-5948838-A | 0.01 TO 5 PARTS BY WEIGHT OF A COMPOUND CONTAINING OXYMETHYLENE UNIT | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-09-07 | — | — | US | disclosed |
| US-5869478-A | ADMINISTERING AS ANTIISCHEMIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-02-09 | — | — | US | disclosed |
| EP-0794218-A2 | Polycarbonate resin composition stabilized against radiation | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-09-10 | — | — | EP | disclosed |
| US-5629429-A | Process for preparing 4-arylamino-benzopyran and related compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-05-13 | — | — | US | disclosed |
| EP-0753540-A2 | Polycarbonate resin composition | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-01-15 | — | — | EP | disclosed |
| EP-0747374-A1 | Sulfonamido substituted benzopyran potassium channel activators | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |